Rivaroxaban 10mg

DRUG4 trials

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University, University of Calgary, Xijing Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Atrial FibrillationHip FracturesMultiple MyelomaPatients With TumorProphylactic AnticoagulationVenous ThromboembolismVenous Thrombosis Due to Central Venous Access Device (Disorder)

Phase 2

HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)

RecruitingNCT05775965

University of CalgaryHip Fractures

Start: 2024-05-21End: 2026-03-01Target: 250Updated: 2025-01-14

Phase 3

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Not yet recruitingNCT06580223

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyMultiple Myeloma, Venous Thromboembolism

Start: 2025-09-01End: 2027-09-01Target: 530Updated: 2025-07-18

Phase 4

Prophylactic Anticoagulation for Catheter-related Thrombosis

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPatients With Tumor, Prophylactic Anticoagulation, Venous Thrombosis Due to Central Venous Access Device (Disorder)

Start: 2020-05-01End: 2022-02-28Target: 1640Updated: 2020-06-30

Unknown Phase

Low-dose NOAC Versus GDMT After LAAO

RecruitingNCT05960721

Xijing HospitalAtrial Fibrillation

Start: 2023-07-06End: 2028-07-30Target: 4220Updated: 2023-07-27